An Open-label, Crossover, Phase 1 Clinical Trial to Evaluate the Pharmacokinetic/pharmacodynamic Drug-drug Interactions and Safety/tolerability of Epaminurad and C2406 When Co-administered in Healthy Adults
Latest Information Update: 05 Nov 2024
At a glance
- Drugs URC 102 (Primary)
- Indications Gout; Kidney disorders
- Focus Pharmacokinetics
- Sponsors JW Pharmaceutical
Most Recent Events
- 05 Nov 2024 New trial record